Open Access

Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT

  • Authors:
    • Lei Jiang
    • Qiying Tang
    • Cedric M. Panje
    • Hongting Nie
    • Guochao Zhao
    • Hongcheng Shi
  • View Affiliations

  • Published online on: May 31, 2018     https://doi.org/10.3892/ol.2018.8859
  • Pages: 1557-1564
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pancreatic colloid carcinoma (CC) is a rare sub‑type of pancreatic adenocarcinoma which has an improved prognosis compared with pancreatic ductal carcinoma. Consequently, the early detection of CC by imaging may be of great significance in guiding patient management and therapeutic decisions. The present study aimed to analyze 18F‑FDG PET/CT findings of CC in comparison to MRI and CT. PET/CT findings in 5 patients with CC were retrospectively reviewed based on visual interpretation and semi‑quantitative index of SUVmax and TNR. Four patients received dual‑time‑point PET/CT scans. Additionally, one patient underwent contrast‑enhanced CT scan, one MRI, and three received both. A total of five lesions were detected in five patients. Visually, two cases presented with mild FDG uptake, two with moderate and one with high. The mean of SUVmax and TNR was 5.1±2.2 and 2.8±0.7, respectively. Compared with CCs with low SUVmax, CCs with high SUVmax were more aggressive. No distant metastases were observed in five cases. Among four patients with dual‑time‑point PET/CT imaging, SUVmax increased in three cases and decreased in one case. The mean early and delayed SUVmax were 4.2±1.1 and 4.7±1.9, respectively (P>0.05). Radiological findings mainly included septated cystic components, internal sponge‑like contrast‑enhancement, calcification and ‘salt‑and‑pepper sign’ on MRI T2‑weighted imaging. Thus, PET/CT provided additional information on metabolic tumor activity as well as locoregional and distant staging, which are important prognostic markers and may improve further patient management. However, PET/CT did not show any findings in addition to MRI and contrast‑enhanced CT that were unique to CC and allowed a clear differentiation from other pancreatic malignancies.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 16 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang L, Tang Q, Panje CM, Nie H, Zhao G and Shi H: Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT. Oncol Lett 16: 1557-1564, 2018
APA
Jiang, L., Tang, Q., Panje, C.M., Nie, H., Zhao, G., & Shi, H. (2018). Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT. Oncology Letters, 16, 1557-1564. https://doi.org/10.3892/ol.2018.8859
MLA
Jiang, L., Tang, Q., Panje, C. M., Nie, H., Zhao, G., Shi, H."Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT". Oncology Letters 16.2 (2018): 1557-1564.
Chicago
Jiang, L., Tang, Q., Panje, C. M., Nie, H., Zhao, G., Shi, H."Assessment of pancreatic colloid carcinoma using 18F‑FDG PET/CT compared with MRI and enhanced CT". Oncology Letters 16, no. 2 (2018): 1557-1564. https://doi.org/10.3892/ol.2018.8859